Arletta Kozłowska, A. Surówka, A. Jaworek, A. Wojas-Pelc
{"title":"唐氏综合症患者的坏疽性脓皮病","authors":"Arletta Kozłowska, A. Surówka, A. Jaworek, A. Wojas-Pelc","doi":"10.5114/lr.2022.122552","DOIUrl":null,"url":null,"abstract":"Pyoderma gangrenosum (PG) is a rare, potentially fatal skin disease with the formation of a painful, rapidly progressing (dynamic) necrotic ulcer with undermined blue-violet margins. PG in 50-70% of patients coexists with other systemic diseases: inflammatory bowel diseases (most frequent), arthritis (most often rheumatoid arthritis – RA), cancer of internal organs, myeloproliferative syndromes","PeriodicalId":130024,"journal":{"name":"Leczenie Ran","volume":"49 4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pyoderma gangrenosum in a patient with Down syndrome\",\"authors\":\"Arletta Kozłowska, A. Surówka, A. Jaworek, A. Wojas-Pelc\",\"doi\":\"10.5114/lr.2022.122552\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pyoderma gangrenosum (PG) is a rare, potentially fatal skin disease with the formation of a painful, rapidly progressing (dynamic) necrotic ulcer with undermined blue-violet margins. PG in 50-70% of patients coexists with other systemic diseases: inflammatory bowel diseases (most frequent), arthritis (most often rheumatoid arthritis – RA), cancer of internal organs, myeloproliferative syndromes\",\"PeriodicalId\":130024,\"journal\":{\"name\":\"Leczenie Ran\",\"volume\":\"49 4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Leczenie Ran\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/lr.2022.122552\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leczenie Ran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/lr.2022.122552","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pyoderma gangrenosum in a patient with Down syndrome
Pyoderma gangrenosum (PG) is a rare, potentially fatal skin disease with the formation of a painful, rapidly progressing (dynamic) necrotic ulcer with undermined blue-violet margins. PG in 50-70% of patients coexists with other systemic diseases: inflammatory bowel diseases (most frequent), arthritis (most often rheumatoid arthritis – RA), cancer of internal organs, myeloproliferative syndromes